SBC Medical GroupvsThermo Fisher Scientific

SBC and TMO stock compared: price, dividend, valuation and results, from SEC filings.

SBC

SBC Medical Group Holdings Incorporated

$6.12

Value $628M

-0.97%
SBC's page

TMO

Thermo Fisher Scientific Inc

$686.79

Value $255B

-0.66%
TMO's page

SBC Medical Group (SBC) has a market value of $628M and Thermo Fisher Scientific (TMO) $255B. Over the last year, with dividends, SBC moved +84.9% and TMO +19.1%. The P/E is 12.1 for SBC and 36.1 for TMO. Dividend yield: SBC none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SBC$628M

    TMO$255B

    TMO is 406 times SBC

  • Revenue, 12 months

    SBC$190M

    TMO$47.4B

    TMO is 249 times SBC

  • Net income, 12 months

    SBC$52M

    TMO$7.1B

    TMO is 136 times SBC

  • Operating margin

    SBC39.9%

    TMO17.9%

    22.0 points apart

  • ROIC

    SBC16.3%

    TMO8.2%

    8.1 points apart

  • P/E

    SBC12.1

    TMO36.1

    TMO is 3.0 times SBC

  • Dividend yield

    SBC0.0%

    TMO0.3%

    0.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SBC-42.5%

TMO+48.7%

50100150202420252026
Returns by period
PeriodSBCWith dividendsTMOWith dividends
1 year since November 14, 2025+84.9%Price +84.9%+19.1%Price +18.7%
3 years since November 17, 2023-42.5%-16.9% a yearPrice -42.5%+48.7%+14.1% a yearPrice +47.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SBCSBC Medical GroupTMOThermo Fisher Scientific

Valuation

SBCTMO
Valuation
Price$6.12$686.79
Market value$628M$255B
Enterprise value (EV)$472M$290B
P/E12.136.1
P/E, 5-year median11.632.7
P/B2.24.7
EV/EBIT6.234.3
Free cash flow yield16.0%3.0%

Results and growth

SBCTMO
Results and growth
Revenue, 12 months$190M$47.4B
Net income, 12 months$52M$7.1B
Free cash flow, 12 months$100M$7.6B
Earnings per share, 12 months$0.50$18.96
Revenue growth, year on year-15.5%3.9%
Revenue growth a year, past-5.3%over 2 years+6.7%over 5 years
EPS growth a year, past+9.1%over 2 years+2.1%over 5 years

Margins and returns on capital

SBCTMO
Margins and returns on capital
Gross margin72.2%–
Operating margin39.9%17.9%
Net margin27.3%14.9%
ROIC16.3%8.2%
ROE19.9%13.4%

Balance sheet

SBCTMO
Balance sheet
Cash$199M$6.1B
Total debt$53M$41.4B
Net debt / EBITDA-2.03.7
Interest cover181.9×5.5×

Dividends and buybacks

SBCTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield0.8%1.2%
Shareholder yield0.8%1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SBC or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, SBC Medical Group or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($255B) is about 406.4 times SBC Medical Group ($628M), at today's prices.

How did SBC and TMO stock do over the last 3 years?

Since November 17, 2023, SBC's price moved -42.5% and TMO's +47.2%. With dividends: SBC -42.5% (-16.9% a year), TMO +48.7% (+14.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, SBC or TMO?

The dividend yield at today's price is none for SBC Medical Group and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of SBC and TMO?

At today's price, the P/E is 12.1 for SBC and 36.1 for TMO. The median of the last five years was 11.6 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, SBC Medical Group or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 27.3% for SBC Medical Group and 14.9% for Thermo Fisher Scientific, and the operating margin 39.9% and 17.9%. Revenue was $190M and $47.4B.

Which is the better investment, SBC Medical Group or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.